Skip to content

VCYT

Veracyte, Inc.

NASDAQ · USHealthcareBiotechnology
$57.26-3.16%

Price as of Jul 20, 2026

VCYT capital

Veracyte, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity
0.03x
Net debt / equity
-0.17x
Debt / assets
0.03x
Debt / EBITDA
0.35x
Net debt / EBITDA
-1.99x

Liquidity & coverage

Current ratio
9.31x
Quick ratio
8.92x
Cash ratio
7.82x
Interest coverage
EBITDA / interest
Working capital
$466.1M

Cash & dividend

FCF / debt
3.94x
Cash flow / debt
4.22x
Dividend per share
Dividend yield
Dividend growth 1y

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.